Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PGx and TDM of Venlafaxine in Depression
NCT04207385Phase 4Unknown
- Sponsor
- Xijing Hospital
- Start
- Dec 2019
- Primary completion
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of venlafaxine in major depressive disorder (MDD), sponsored by Xijing Hospital. Status: unknown.
02
Drugs
venlafaxine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT04207385.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04207385.